Peter Imhof says take a pass on pricey Kinaxis

Peter Imhof

Kinaxis Inc. (Kinaxis Inc. Stock Quote, Chart, News: TSX:KXS) is a great stock to hold if you already own it, but don’t jump in at its current price, says Peter Imhof, vice-president and portfolio manager at AGF Investments, who claims that KXS’s multiple is just too high.

So far, supply chain management software company Kinaxis has had a superb run.. The Ottawa-based SaaS business has seen its share price climb 30 per cent since mid-2016 and over 500 per cent since its IPO in 2014, even as the company keeps picking up big name clients.

Kinaxis just announced that global biopharmaceutical company Ipsen has chosen the company to manage its supply chain, while a number of auto manufacturers have also been signed up, including Toyota, Nissan, Ford and Volvo.

Imhof says that Kinaxis is one of a small handful of excellent IPOs in Canada over the past five years.

“You can talk about Kinaxis, Shopify, Spinmaster, Canada Goose and Jamieson Vitamins — and most of the other ones haven’t done extremely well,” Imhof said to BNN Bloomberg. “It’s a very good story.”

Imhof spoke of last year’s breach of contract dispute with electronics giant Samsung, which caused a significant drop in KXS’s share price.

“It went up to $80 and then came down to about $70 after it lost Samsung,” he says. “There was a dispute there. To be quite honest, I think Samsung didn’t treat them well and was trying to cut down their margins quite a bit and Kinaxis said, ‘Well, if that’s the way you want to play, we’re going to exit this agreement.’ It scared a lot of people out of the stock.”

But Imhof claims that at 70x forward earnings (Kinaxis has a market capitalization of US$2.1 billion and a share price currently in the mid-$80 range), the stock is too expensive right now.

“It’s been a really good story and I really like the management team,” he says. “They have a lot of great reference customers, and I think that’s how they continue to grow. It’s just that the multiple for me to re-enter it right now is a little bit high.”

“In the US, the tech sector has done incredibly well, so that’s why these multiples are so high, even in Canada on SaaS names,” says Imhof.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: kxs
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

2 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

2 days ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

2 days ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

3 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

4 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

4 days ago